Impact of sorafenib on epidural fibrosis: An immunohistochemical study

doi:10.12998/wjcc.v6.i9.249

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6355)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

389

WORD

219

HTML

2849

Figures (1-4)

366

Tables (1-3)

288

Sum=4111

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

899

Download

1345

Sum=2244

Sep 6, 2018 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Cases. Sep 6, 2018; 6(9): 249-258
Published online Sep 6, 2018. doi: 10.12998/wjcc.v6.i9.249

Table 2 Microvessels visualized by CD105 immunostaining

Grade	Average number of microvessels (400 x)
1	≤ 3
2	4-6
3	≥ 7

Citation: Tanriverdi O, Erdogan U, Tanik C, Yilmaz I, Gunaldi O, Adilay HU, Arslanhan A, Eseoglu M. Impact of sorafenib on epidural fibrosis: An immunohistochemical study. World J Clin Cases 2018; 6(9): 249-258
URL: https://www.wjgnet.com/2307-8960/full/v6/i9/249.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i9.249